LC
Laura Chico Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
71
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
73.9%
Neutral
21.7%
Negative
4.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Residential Construction
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $63 |
6%
upside
| 2 | +24% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $58 |
106%
upside
| 1 | +72% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $17 |
97%
upside
| 2 | +40% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $103 |
10%
upside
| 4 | +21% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $44 |
197%
upside
| 1 | -4.5% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $24 |
5%
upside
| 1 | +16% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $14 |
53%
upside
| 2 | -0.12% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $12 |
150%
upside
| 2 | +19% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $18 |
56%
downside
| 1 | – |
–
| 25 Feb ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $1 |
124%
upside
| 1 | +13% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Outperform
Reiterated
| $19 |
195%
upside
| 2 | +18% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Underperform
Maintained
| $130 |
62%
downside
| 2 | -77% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Neutral
Reiterated
| $25 |
1%
upside
| 1 | – |
–
| 17 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $151 |
13%
upside
| 1 | -2.2% |
0
%
| 12 Feb ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $187 |
5%
upside
| 2 | – |
–
| 10 Feb ‘26 2 months ago |
|